STOCK TITAN

Perrigo (NYSE: PRGO) EVP awarded 8,019 shares and exercises RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Perrigo Company plc executive Robert Willis, EVP & CHRO, reported compensation-related equity activity involving restricted stock units and ordinary shares. On March 6, 2026, he exercised performance-based and time-based restricted stock units into a total of 4,501 ordinary shares, with related non-derivative entries showing a reported price of $10.72 per share. The filing also shows a separate grant of 8,019 ordinary shares as a share award. To cover tax obligations, 6,524 ordinary shares were withheld through transactions coded “F,” which are not open-market sales. Following these transactions, Willis directly holds 47,935 Perrigo ordinary shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Willis Robert

(Last) (First) (Middle)
PERRIGO COMPANY PLC
515 EASTERN AVENUE

(Street)
ALLEGAN MI 49010

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PERRIGO Co plc [ PRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & CHRO
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 03/06/2026 M 2,743 A $10.72 44,682 D
Ordinary Shares 03/06/2026 F 1,430 D $10.72 43,252 D
Ordinary Shares 03/06/2026 M 1,758 A $10.72 45,010 D
Ordinary Shares 03/06/2026 F 916 D $10.72 44,094 D
Ordinary Shares 03/06/2026 A(1) 8,019 A $10.72 52,113 D
Ordinary Shares 03/06/2026 F 4,178 D $10.72 47,935 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 03/06/2026 M 2,743 (3) (3) Ordinary Shares 2,743 (4) 2,742 D
Restricted Stock Units (4) 03/06/2026 M 1,758 (5) (5) Ordinary Shares 1,758 (4) 0 D
Explanation of Responses:
1. Vesting of performance-based restricted stock units granted on March 6, 2023
2. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
3. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 2 equal annual installments beginning 6 March 2026.
4. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
5. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024.
Remarks:
/s/ Diana Witt, attorney-in-fact for Mr. Robert Willis 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Perrigo (PRGO) executive Robert Willis report in this Form 4?

Robert Willis, Perrigo’s EVP & CHRO, reported equity compensation activity. He exercised restricted stock units into ordinary shares, received an additional share grant, and had shares withheld to cover tax obligations, all on March 6, 2026, with no open-market buys or sells disclosed.

How many Perrigo shares did Robert Willis acquire from RSU vesting?

Willis acquired 4,501 Perrigo ordinary shares through the exercise of restricted stock units. These exercises converted previously granted performance-based and time-based RSUs into ordinary shares, as indicated by transaction code M and supported by footnotes describing the original grant and vesting terms.

What new Perrigo share grant did Robert Willis receive?

The Form 4 shows Willis received a grant of 8,019 Perrigo ordinary shares, coded as an award acquisition (code A). This represents additional equity compensation rather than a market purchase, increasing his direct share ownership as part of his executive compensation package.

Were any Perrigo shares sold by Robert Willis in the open market?

The filing does not show any open-market sales. Dispositions are coded F, meaning shares were withheld to pay exercise price or tax liabilities. In total, 6,524 shares were withheld for these obligations, which is a common, non-market mechanism tied to equity compensation events.

How many Perrigo shares does Robert Willis hold after these transactions?

After completing the RSU exercises, share grant, and tax-withholding entries, Willis directly holds 47,935 Perrigo ordinary shares. This post-transaction balance reflects his updated ownership position as reported in the final line of the non-derivative transaction table.

What were the reported prices used in Robert Willis’s Perrigo share transactions?

Non-derivative transactions involving Perrigo ordinary shares used a reported price of $10.72 per share. This price appears on both the acquisition entries from RSU conversion and the F-coded tax-withholding dispositions and serves as the reference value for those share movements.
Perrigo Co Plc

NYSE:PRGO

View PRGO Stock Overview

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

1.30B
137.06M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2